Terms: = Lymphoma AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2 AND Treatment
24 results:
1. Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies.
R P; Shanmugam G; Rakshit S; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155026. PubMed ID: 38118219
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Features and Genetic Analysis of Taiwanese Primary Immunodeficiency Patients with Prolonged Diarrhea and Monogenetic Inflammatory Bowel Disease.
Lee WI; Chen CC; Chen SH; Lai WT; Jaing TH; Ou LS; Liang CJ; Kang CC; Huang JL
J Clin Immunol; 2023 Aug; 43(6):1455-1467. PubMed ID: 37202577
[TBL] [Abstract] [Full Text] [Related]
3. Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
Eikeland SA; Smeland KB; Simensen VC; Fagerli UM; Bersvendsen HS; Kiserud CE; Fosså A
Acta Oncol; 2023 Jan; 62(1):80-88. PubMed ID: 36715320
[TBL] [Abstract] [Full Text] [Related]
4. Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care.
Agarwal N; Citla Sridhar D; Malay S; Patil N; Shekar A; Ahuja S; Dalal J
Sci Rep; 2021 Feb; 11(1):4654. PubMed ID: 33633315
[TBL] [Abstract] [Full Text] [Related]
5. A Novel Peptide from Vespa ducalis Induces Apoptosis in Osteosarcoma Cells by Activating the p38 MAPK and JNK Signaling Pathways.
Wu R; Li D; Tang Q; Wang W; Xie G; Dou P
Biol Pharm Bull; 2018; 41(4):458-464. PubMed ID: 29607921
[TBL] [Abstract] [Full Text] [Related]
6. A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases.
Lee WI; Chen CC; Jaing TH; Ou LS; Hsueh C; Huang JL
Sci Rep; 2017 Jun; 7(1):3669. PubMed ID: 28623282
[TBL] [Abstract] [Full Text] [Related]
7. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.
Kritikou JS; Dahlberg CI; Baptista MA; Wagner AK; Banerjee PP; Gwalani LA; Poli C; Panda SK; Kärre K; Kaech SM; Wermeling F; Andersson J; Orange JS; Brauner H; Westerberg LS
Sci Rep; 2016 Aug; 6():30636. PubMed ID: 27477778
[TBL] [Abstract] [Full Text] [Related]
8. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract] [Full Text] [Related]
9. Successful treatment of non-Hodgkin's lymphoma using R-CHOP in a patient with Wiskott-Aldrich syndrome followed by a reduced-intensity stem cell transplant.
Koga Y; Takada H; Suminoe A; Ohga S; Hara T
Pediatr Transplant; 2014 Sep; 18(6):E208-11. PubMed ID: 24930759
[TBL] [Abstract] [Full Text] [Related]
10. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.
Tavil B; Erdem AY; Azik F; Isik P; Metin A; Emir S; Uckan D; Tunc B
Pediatr Transplant; 2013 Sep; 17(6):E146-8. PubMed ID: 23773507
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics of children with non-hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients.
Emir S; Vezir E; Azkur D; Demir HA; Metin A
Pediatr Hematol Oncol; 2013 Sep; 30(6):544-53. PubMed ID: 23647505
[TBL] [Abstract] [Full Text] [Related]
12. treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome.
Coccia P; Mastrangelo S; Ruggiero A; Scalzone M; Rosolen A; Maurizi P; Riccardi R
Pediatr Blood Cancer; 2012 Aug; 59(2):318-9. PubMed ID: 22052860
[TBL] [Abstract] [Full Text] [Related]
13. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Lakatosh SA; Barcia J; Guzmán M; Velasco G
Cell Death Differ; 2011 Jun; 18(6):959-73. PubMed ID: 21233844
[TBL] [Abstract] [Full Text] [Related]
14. [Expression of WAVE1 in childhood acute lymphocytic leukemia and in the apoptosis of Jurkat cells induced by adriamycin].
Wang Z; Hu T; Cao LZ; Kang R; Zhao MY; Yu Y; Xu WQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):620-4. PubMed ID: 18947485
[TBL] [Abstract] [Full Text] [Related]
15. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
[TBL] [Abstract] [Full Text] [Related]
17. Induction of intracellular calcium elevation by Delta9-tetrahydrocannabinol in T cells involves TRPC1 channels.
Rao GK; Kaminski NE
J Leukoc Biol; 2006 Jan; 79(1):202-13. PubMed ID: 16244107
[TBL] [Abstract] [Full Text] [Related]
18. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.
Dupré L; Trifari S; Follenzi A; Marangoni F; Lain de Lera T; Bernad A; Martino S; Tsuchiya S; Bordignon C; Naldini L; Aiuti A; Roncarolo MG
Mol Ther; 2004 Nov; 10(5):903-15. PubMed ID: 15509508
[TBL] [Abstract] [Full Text] [Related]
19. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy.
Sebire NJ; Haselden S; Malone M; Davies EG; Ramsay AD
J Clin Pathol; 2003 Jul; 56(7):555-7. PubMed ID: 12835306
[TBL] [Abstract] [Full Text] [Related]
20. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
McKallip RJ; Lombard C; Fisher M; Martin BR; Ryu S; Grant S; Nagarkatti PS; Nagarkatti M
Blood; 2002 Jul; 100(2):627-34. PubMed ID: 12091357
[TBL] [Abstract] [Full Text] [Related]
[Next]
